Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea: Changes in Microfilaremia, Filarial Antigen, and Bm14 Antibody after Cessation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.